NCT00903916
- Conditions
- Body Weight, Body Weight Changes, Mental Disorders, +5 more
- Locations
-
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
Clinical trial condition
Schizophrenia Spectrum and Other Psychotic Disorders
Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.
3,086 public trials
346 recruiting studies
Schizophrenia Spectrum and Other Psychotic Disorders trial results
Completed
Glycine Treatment of Prodromal Symptoms
NCT00268749
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
Not specified
NCT01181934
- Conditions
- Cognition Disorders, Mental Disorders, Neurocognitive Disorders, +2 more
- Locations
-
Not specified
Completed
The Effect of Nicotine on Arousal, Cognition and Social Cognition in Schizophrenic Patients
NCT01186471
- Conditions
- Cognition Disorders, Mental Disorders, Neurocognitive Disorders, +2 more
- Locations
-
Not specified
NCT00565175
- Conditions
- Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +11 more
- Locations
-
- HUCH Department of Psychiatry Helsinki, Finland
- Kellokosken sairaala Kellokoski, Finland
- Lohjan sairaanhoitoalue Lohja, Finland
- Vaasa Hospital District Vaasa, Finland
NCT01548612
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- University General Hospital of the Ribeirao Preto Medical School Ribeirão Preto, São Paulo, Brazil
Completed
Magnetoencephalographic (MEG) Evidence for Novel Metaphor Processing Among Schizophrenic Patients
NCT01325363
- Conditions
- Mental Disorders, Novel Metaphor, Schizophrenia, +1 more
- Locations
-
- shalvata MHC Hod HaSharon, Israel
NCT00572247
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders, +1 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States
NCT00970281
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Gunma, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
Completed
Evaluation of the Safety and Efficacy of Memantine as Adjunctive Treatment in Schizophrenia Patients
NCT00097942
- Conditions
- Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
- Locations
-
- Synergy Clinical Research National City, California, United States
- VA San Diego Healthcare System San Diego, California, United States
- University of Miami Jackson Memorial Hospital Miami, Florida, United States
- University of Iowa Psychiatric Research Iowa City, Iowa, United States